116 related articles for article (PubMed ID: 25174563)
1. Strong improvement of apolipoprotein E/low-density lipoprotein receptor signals by telmisartan in poststroke spontaneously hypertensive stroke resistant.
Yamashita T; Zhai Y; Kurata T; Hishikawa N; Morimoto N; Ohta Y; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2240-9. PubMed ID: 25174563
[TBL] [Abstract][Full Text] [Related]
2. Strong reduction of low-density lipoprotein receptor/apolipoprotein E expressions by telmisartan in cerebral cortex and hippocampus of stroke resistant spontaneously hypertensive rats.
Zhai Y; Yamashita T; Kurata T; Fukui Y; Sato K; Kono S; Liu W; Omote Y; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2350-61. PubMed ID: 25194744
[TBL] [Abstract][Full Text] [Related]
3. Long-term amelioration of telmisartan on metabolic syndrome-related molecules in stroke-resistant spontaneously hypertensive rat after transient middle cerebral artery occlusion.
Deguchi K; Kurata T; Fukui Y; Liu W; Yun Z; Omote Y; Sato K; Kono S; Hishikawa N; Yamashita T; Abe K
J Stroke Cerebrovasc Dis; 2014; 23(10):2646-2653. PubMed ID: 25307428
[TBL] [Abstract][Full Text] [Related]
4. Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke.
Kono S; Kurata T; Sato K; Omote Y; Hishikawa N; Yamashita T; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):537-47. PubMed ID: 25534368
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan ameliorates inflammatory responses in SHR-SR after tMCAO.
Sato K; Yamashita T; Kurata T; Fukui Y; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014; 23(10):2511-2519. PubMed ID: 25245484
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan reduces progressive oxidative stress and phosphorylated α-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion.
Sato K; Yamashita T; Kurata T; Lukic V; Fukui Y; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1554-63. PubMed ID: 24780412
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of telmisartan against progressive oxidative brain damage and synuclein phosphorylation in stroke-resistant spontaneously hypertensive rats.
Fukui Y; Yamashita T; Kurata T; Sato K; Lukic V; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1545-53. PubMed ID: 24685992
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats.
Liu W; Yamashita T; Kurata T; Kono S; Hishikawa N; Deguchi K; Zhai Y; Abe K
Neurol Res; 2015 Jun; 37(6):491-501. PubMed ID: 25591419
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan promotes potential glucose homeostasis in stroke-resistant spontaneously hypertensive rats via peroxisome proliferator-activated receptor γ activation.
Omote Y; Deguchi K; Kurata T; Yamashita T; Sato K; Hishikawa N; Abe K
Curr Neurovasc Res; 2015; 12(1):91-7. PubMed ID: 25557372
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 1 receptor blocker telmisartan reduces cerebral infarct volume and peri-infarct cytosolic phospholipase A(2) level in experimental stroke.
Kobayashi T; Kawamata T; Shibata N; Okada Y; Kobayashi M; Hori T
J Neurotrauma; 2009 Dec; 26(12):2355-64. PubMed ID: 19604102
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan reduces progressive accumulation of cellular amyloid beta and phosphorylated tau with inflammatory responses in aged spontaneously hypertensive stroke resistant rat.
Kurata T; Lukic V; Kozuki M; Wada D; Miyazaki K; Morimoto N; Ohta Y; Deguchi K; Ikeda Y; Kamiya T; Abe K
J Stroke Cerebrovasc Dis; 2014; 23(10):2580-2590. PubMed ID: 25241340
[TBL] [Abstract][Full Text] [Related]
12. Long-term effect of telmisartan on Alzheimer's amyloid genesis in SHR-SR after tMCAO.
Kurata T; Lukic V; Kozuki M; Wada D; Miyazaki K; Morimoto N; Ohta Y; Deguchi K; Yamashita T; Hishikawa N; Matsuzono K; Ikeda Y; Kamiya T; Abe K
Transl Stroke Res; 2015 Apr; 6(2):107-15. PubMed ID: 24435631
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOS pathways in spontaneously hypertensive rats.
Wang WW; Zhang FL; Chen JH; Chen XH; Fu FY; Tang MR; Chen LL
Can J Physiol Pharmacol; 2015 Aug; 93(8):657-65. PubMed ID: 26158699
[TBL] [Abstract][Full Text] [Related]
14. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M
Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951
[TBL] [Abstract][Full Text] [Related]
15. Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice.
Iwanami J; Mogi M; Tsukuda K; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
J Hypertens; 2010 Aug; 28(8):1730-7. PubMed ID: 20498620
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of angiotensin II type 1 receptor blocker on cerebral circulation independent of blood pressure.
Kumai Y; Ooboshi H; Ago T; Ishikawa E; Takada J; Kamouchi M; Kitazono T; Ibayashi S; Iida M
Exp Neurol; 2008 Apr; 210(2):441-8. PubMed ID: 18177860
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan exerts sustained blood pressure control and reduces blood pressure variability in metabolic syndrome by inhibiting sympathetic activity.
Sueta D; Koibuchi N; Hasegawa Y; Toyama K; Uekawa K; Katayama T; Ma M; Nakagawa T; Ogawa H; Kim-Mitsuyama S
Am J Hypertens; 2014 Dec; 27(12):1464-71. PubMed ID: 24871627
[TBL] [Abstract][Full Text] [Related]
18. Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats.
Omura-Matsuoka E; Yagita Y; Sasaki T; Terasaki Y; Oyama N; Sugiyama Y; Okazaki S; Sakoda S; Kitagawa K
Hypertens Res; 2009 Jul; 32(7):548-53. PubMed ID: 19424281
[TBL] [Abstract][Full Text] [Related]
19. Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling.
Takai S; Kirimura K; Jin D; Muramatsu M; Yoshikawa K; Mino Y; Miyazaki M
Hypertens Res; 2005 Jul; 28(7):593-600. PubMed ID: 16335888
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
